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Reply to the letter from Poljak et al
Sir - In their letter Poljak et al. expressed their experience in
processing of archival cervical smears for human papilloma-
virus (HPV) detection by polymerase chain reaction (PCR).
In agreement with our observation, they found that a
complete DNA extraction procedure is required for a
successful amplification by PCR. However, they claim that
DNA of sufficient molecular weight can easily be isolated to
allow amplification of DNA fragments longer than 200 bp.
This is in contrast to our findings, showing that it is far from
easy to extract sufficient amounts of larger DNA fragments,
particularly from older smears. It should be noted that this
discrepancy may reflect differences in preparation of the
Papanicolaou smear. In particular, the fixation procedure
used might be of importance, as the preservation of nucleic
acids is likely to be fixation dependent. It is well known that
among the different cytological laboratories different fixatives
are used to ensure an optimal morphology. This was
discussed in our paper. Obviously, the fact that Poljak et
al. were able to extract relatively large DNA fragments from
their older smears reflects a better preservation of nucleic
acids than in the long-stored smears analysed in our
laboratory. However, our studies also revealed long-stored
smears from which larger fragments could be amplified,
indicating that the correlation between storage time and
mean fragment size is not strictly linear. Because of the lack
of proper documentation, we do not know if some of the
long-stored smears analysed in our study were originally fixed
in another way, which could be an alternative explanation for
the observed differences.
Concerning the complexity of the GTC/silica beads
method, we have the impression that, based on recent
experiments, the use of diatoms rather than silica particles
improves the yield after one extraction round. The use of
diatoms has been described as one of the alternatives in the
GTC/silica protocol (Boom et al., 1990). Currently, we have
no explanation for this observation, but since diatoms are
much larger than size-fractionated silica particles, it is
conceivable that diatoms display less stringent requirements
for nucleic acids binding.
Although we did not test the -30°C/37°C alternate
incubation protocol for removal of coverslips, this sugges-
tion is of interest and may save time.
In conclusion, before definitive conclusions can be drawn
about the feasibility ofdifferent extraction methods, the effect
offixatives used for preparing Pap smears has to be analysed.
JMM Walboomers
PJF Snijders
AM de Roda Husman
Unit of Molecular Pathology
Department of Pathology
Free University Hospital
De Boelelaan 1117
1081 HV Amsterdam
The Netherlands
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Cancers related to contraceptive use
Sir - There is another hypothesis in addition to contraceptive
use or oestrogen replacement therapy to account for the
changing gender ratios of colorectal cancer reported by Silva
and Swerdlow (1996). In their discussion of declining F/M
incidence ratios, the authors overlooked the contribution that
non-steroidal anti-inflammatory drugs (NSAIDs) may have.
NSAIDs inhibit prostaglandin synthesis, which is elevated in
human colorectal cancers, in venous blood therefrom and in
peripheral blood in patients with metastases (Marnett, 1992;
Narisawa et al., 1990). NSAID therapy reduced the incidence
of carcinogen-induced large bowel neoplasms in rodents,
unlike oral contraceptives or oestrogens. Aspirin and newer
NSAIDs have delayed recurrence of polyps in hereditary
polyposis of the colon and reduced by 30-50% colorectal
cancer development in case-control and prospective clinical
trials (Giardiello et al., 1995; Giovannucci et al., 1995).
Salicylates have been available since early in this century,
and newer synthetic NSAIDs have been widely used for pain
relief only during the past 30 years. The latter have been very
profitable and hence heavily advertised. Not counting over-
the-counter sales, well over 70 000 000 prescriptions for these
drugs are filled annually in the US. In addition to
premenstrual symptoms, women have about 60% more
headaches, arthritis and back pains than men (Benson and
Marano, 1994). Women also have more sluggish colonic
peristalsis than men, perhaps increasing their cancer risk
(Lampe et al., 1993).
Since 1940, colorectal cancer mortality rates (age adjusted
to the 1970 US population) in US women has declined with
little change in men; the F/M ratio fell from 1.0 to 0.68
(Wingo et al., 1995; Page and Asire, 1985; Riss et al., 1994).
Since 1970, the Nesbraska ratio has declined by over 40%,
falling from 0.93 to 0.53, resulting in 200+ fewer deaths
annually. From 1987 to 1993, there were no significant
gender differences in staging or operability of these tumours
in our state (Nebraska Dept. of Health, 1991).
Consumer surveys are needed to determine which of these
therapies may be most important in contributing to this
welcome decrease in the incidence and mortality of colorectal
cancer in women, but not yet in men.
Bryan A Rettig,
Planning and Data Analysis Support Section,
Nebraska Department of Health,
PO Box 95007,
Lincoln,
NE 68509-5007.
Henry M Lemon,
Section of Oncology and Hematology,
Department of Internal Medicine,
University ofNebraska Medical Center,
Omaha,
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Reply to the letter from Rettig and Lemon
Sir - In their letter, Rettig and Lemon raised the possibility
that non-steroidal anti-inflammatory drugs (NSAIDs) may
have contributed to the sex differences in time trends of
colorectal cancer in England and Wales. We agree that this is
an interesting possibility; there are some data available to
examine it. The total number of prescriptions (excluding
preparations sold over the counter) for NSAIDs other than
aspirin increased markedly in the United Kingdom from 7.6
million in 1967 to 22 million in 1985 (Walt et al., 1986). The
increase occurred in both sexes but prescription rates were
40-60% higher in women than in men throughout the
period.
Data on aspirin consumption are available from a
nationally representative survey carried out in Great Britain
in 1973 (OPCS, 1976). In this survey, women were 36% more
likely than men to have consumed any analgesics containing
aspirin in the week preceding the survey (Table I); this female
excess was particularly marked at ages 45-64 years. Among
consumers, women were also more likely to have taken these
drugs more often: 58% of women had taken these drugs at
least twice a week, whereas the corresponding figure for men
was 48%.
The increase in NSAID consumption may have contrib-
uted to the decrease in the risk of colorectal cancer in women
in England and Wales in recent years. However, the
consumption of these drugs has also increased markedly in
men (although less than in women) but no decline in their
cancer risks has yet been observed. The few analytical studies
conducted so far with sex-specific data do not seem to
indicate that the effect of these drugs on the risk of
developing colorectal cancer may be greater in women than
in men (Muscat et al., 1994; Rosenberger et al., 1991).
Table I Rates per 1000 persons taking analgesics containing aspirin
in the week preceding the survey, by sex and age (Great Britain,
1973)
Age (years)
J16 16-44 45-64 65- 74
Females 216 246 204 172
(n= 12 146)
Males 159 183 60 105
(n = 10588)
F:M ratio 1.36 1.34 3.4 1.64
Data from Office of Population Censuses and Surveys (1976).
We agree with Rettig and Lemon that further research is
needed to clarify the reasons for the observed decline in the
risk of colorectal cancer in women but not in men and, in
particular, the potential role of oral contraceptive and
NSAID use.
Isabel dos Santos Silva,
AJ Swerdlow
Epidemiological Monitoring Unit,
Department of Epidemiology and Population Sciences,
London School of Hygiene and Tropical Medicine,
Keppel Street,
London, WCJE 7HT
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